The PKD1 gene helps cells in the kidneys and some other organs sense fluid flow and keep tiny tubes structurally stable. This gene plays an important role in limiting cyst growth, so a pathogenic variant can lead to many fluid filled cysts, most often in the kidneys. If you carry a disease causing change, you may develop a condition called autosomal dominant polycystic kidney disease, which can bring enlarged kidneys, high blood pressure, pain, and gradually reduced kidney function. Some people also develop liver cysts.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Others mainly control when certain processes take place, where they take place, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
PKD1Gene function
What if the gene works
The PKD1 gene helps kidney cells sense fluid flow and communicate with each other. This supports normal growth and structure of kidney tubules and some other tissues.
Risk
What if the gene does not work
Disease-causing variants in the PKD1 gene usually cause autosomal dominant polycystic kidney disease, with kidney cysts that enlarge the kidneys and reduce function over time. Some also develop liver cysts, and more disruptive variants often bring earlier or stronger features.
Treatment
What does that mean for your treatment
A pathogenic variant in the PKD1 gene can support a higher risk assessment, especially for truncating variants, which may make tolvaptan more likely to be considered in adults at risk of rapid kidney decline. Drug choices and management still depend on the full clinical picture, including age, kidney function, kidney size, and how fast the condition is changing.
Conditions associated with PKD1
Gene function
What if the gene works
In everyday cell work, the PKD1 gene helps cells read physical cues from their surroundings and stay organized. Its protein is especially important in the kidney, where tiny tubules need to sense fluid movement and keep a stable shape. It also supports communication between neighboring cells and the tissue around them.
In kidney tubules, the PKD1 gene helps cells respond to fluid moving past them. This supports normal signals that help the tubules keep their orderly, tube-like shape.
Its protein sits at the cell surface and in the primary cilium (a small sensing projection). There it helps relay outside cues into the cell so everyday responses stay coordinated.
Working with a partner protein, the PKD1 gene helps shape calcium signals inside cells. These brief signals guide routine activities such as growth, movement, and secretion.
The PKD1 gene also supports how cells connect with nearby cells and the surrounding support layer. Stable connections help many tissues, especially kidney tubules, keep their structure.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can affect how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PKD1 gene can change the size, shape, or stability of its protein, so cells may make too little of it, break it down early, or fail to place it correctly on the cell surface. This shows how PKD1 variants affect protein function, including weaker contact with partner proteins and less reliable signaling between kidney cells. Milder variants may leave some activity, while more severe variants, such as protein-shortening changes, often have a larger effect and can be linked to earlier or more noticeable polycystic kidney disease.
How variants are linked to conditions
Pathogenic variants in the PKD1 gene cause autosomal dominant polycystic kidney disease, often called ADPKD. In many people, PKD1 gene variants and polycystic kidney disease are linked to kidney cysts that enlarge over time, high blood pressure, and a higher chance of reduced kidney function in adulthood. Some also develop liver cysts. Compared with PKD2-related ADPKD, PKD1-related disease often starts earlier and is more likely to affect kidney function sooner.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PKD1, the chance of developing polycystic kidney disease is usually mainly set by whether you inherited a harmful variant, so lifestyle changes do not reliably prevent the condition. Risk and severity can still vary within families, and high blood pressure, smoking, and excess body weight can speed kidney damage and related problems.
Inheritance of PKD1 variants
PKD1-related polycystic kidney disease is usually inherited in an autosomal dominant pattern, which means a parent carrying a disease-causing variant in the PKD1 gene has a 50% chance of passing it to each child. This is the key point behind how PKD1 gene variants are inherited in families: sons and daughters are affected equally, and the variant can be passed from either parent. Some people have a new (de novo) variant in the PKD1 gene, so they are the first person in the family to have it.
What does my PKD1 result mean for my family?
For families with a disease-causing change in the PKD1 gene, close relatives such as parents, brothers, sisters, and children may also carry the same change and may have or later develop kidney cysts. PKD1-related polycystic kidney disease usually runs in families in a dominant way, so each child of an affected parent has a 1 in 2 chance of inheriting it. In some families, the change starts new in one person, so it is not always passed down from a parent.
Genetic information
Genetic testing
How you find out about variants
PKD1 genetic testing for polycystic kidney disease usually uses a blood or saliva sample to read the PKD1 gene and look for variants. Results can help show whether a DNA change may explain kidney cysts or a family history, although some findings need careful interpretation.
When should I consider getting a genetic test?
Consider PKD1 genetic testing if you or close relatives have many kidney cysts, enlarged kidneys, early high blood pressure, or kidney failure that runs in the family. Testing can help confirm inherited polycystic kidney disease and may clarify the chance that children or siblings could also have it.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains varies by the condition and the type of variant involved. Over time, how the body works is also shaped by factors such as age, lifestyle, environment, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. In some people, the body breaks down or moves a drug differently, while in others the tissues that the drug acts on may be more or less sensitive. These differences are common and are one part of why medication response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how the body processes a drug and how strongly that drug works. This information can help guide treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the PKD1 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding how medicines are chosen or used, so if you have concerns about treatment, side effects, or changes in your health, talk with your doctor.
History
For many years, doctors recognized that enlarged kidneys with many cysts could run in families, long before the responsible gene was known. In the 1980s, researchers linked the condition to a region on chromosome 16, which was a major step in understanding inherited polycystic kidney disease. From these first observations, research expanded steadily. In 1994, the PKD1 gene was identified, although this took extra work because the gene sits in a part of the genome with several very similar copied stretches nearby. That discovery helped confirm why many families had an inherited form of the condition. Since then, the PKD1 gene has remained central to research on diagnosis, inheritance, and the history of kidney genetics.